{"status":"OK","data":{"id":3194690,"identifier":"DVN/OWJEUN","persistentUrl":"https://doi.org/10.7910/DVN/OWJEUN","protocol":"doi","authority":"10.7910","publisher":"Harvard Dataverse","publicationDate":"2018-07-20","storageIdentifier":"s3://10.7910/DVN/OWJEUN","latestVersion":{"id":139651,"storageIdentifier":"s3://10.7910/DVN/OWJEUN","versionNumber":1,"versionMinorNumber":0,"versionState":"RELEASED","productionDate":"Production Date","lastUpdateTime":"2018-07-20T18:30:41Z","releaseTime":"2018-07-20T18:30:41Z","createTime":"2018-07-20T18:27:02Z","license":"CC0","termsOfUse":"CC0 Waiver","metadataBlocks":{"citation":{"displayName":"Citation Metadata","fields":[{"typeName":"title","multiple":false,"typeClass":"primitive","value":"2012-2018 Inter Partes Review Outcomes of Orange Book-Listed Drug Patents"},{"typeName":"author","multiple":true,"typeClass":"compound","value":[{"authorName":{"typeName":"authorName","multiple":false,"typeClass":"primitive","value":"Mahaseth, Tulip"},"authorAffiliation":{"typeName":"authorAffiliation","multiple":false,"typeClass":"primitive","value":"Northwestern University School of Law"}}]},{"typeName":"datasetContact","multiple":true,"typeClass":"compound","value":[{"datasetContactName":{"typeName":"datasetContactName","multiple":false,"typeClass":"primitive","value":"Mahaseth, Tulip"},"datasetContactAffiliation":{"typeName":"datasetContactAffiliation","multiple":false,"typeClass":"primitive","value":"Northwestern University School of Law"},"datasetContactEmail":{"typeName":"datasetContactEmail","multiple":false,"typeClass":"primitive","value":"tulipmahaseth@gmail.com"}}]},{"typeName":"dsDescription","multiple":true,"typeClass":"compound","value":[{"dsDescriptionValue":{"typeName":"dsDescriptionValue","multiple":false,"typeClass":"primitive","value":"This database contains information regarding all 412 IPRs filed against 230 Orange Book (OB) patents between 03/16/2012 and 03/16/2018 including 1) their outcomes, 2) type of petitioners filing these IPRs, 3) type of drug exclusivity and OB products related to the OB patents, 3) whether the OB patents were subsequently acquired, and 4) the types of diseases the OB patents treated. \r\n\r\nI have written a paper based on my analysis of this data titled \"Maintaining the Balance: An Empirical Study on Inter Partes Review Outcomes of Orange Book-Listed Drug Patents and its Effect on Hatch-Waxman Litigation,\" which can be found here: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3188995\r\n"}}]},{"typeName":"subject","multiple":true,"typeClass":"controlledVocabulary","value":["Law","Medicine, Health and Life Sciences"]},{"typeName":"keyword","multiple":true,"typeClass":"compound","value":[{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"Orange Book patents"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"IPR"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"Hatch-Waxman"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"ANDA"}}]},{"typeName":"publication","multiple":true,"typeClass":"compound","value":[{"publicationCitation":{"typeName":"publicationCitation","multiple":false,"typeClass":"primitive","value":"Maintaining the Balance: An Empirical Study on Inter Partes Review Outcomes of Orange Book-Listed Drug Patents and its Effect on Hatch-Waxman Litigation\r\n"},"publicationURL":{"typeName":"publicationURL","multiple":false,"typeClass":"primitive","value":"https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3188995"}}]},{"typeName":"depositor","multiple":false,"typeClass":"primitive","value":"Mahaseth, Tulip"},{"typeName":"dateOfDeposit","multiple":false,"typeClass":"primitive","value":"2018-07-20"}]}},"files":[{"description":"This database contains information regarding all 412 IPRs filed against 230 Orange Book (OB) patents between 03/16/2012 and 03/16/2018 including  1) their outcomes, 2) type of petitioners filing these IPRs, 3) type of drug exclusivity and OB products related to the OB patents, 3) whether the OB patents were subsequently acquired, and 4) the types of diseases the OB patents treated. \r\n\r\nI have written a paper based on my analysis of this data titled \"Maintaining the Balance: An Empirical Study on Inter Partes Review Outcomes of Orange Book-Listed Drug Patents and its Effect on Hatch-Waxman Litigation,\" which can be found here: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3188995","label":"2012-2018 Orange Book Patents IPRs Database.xlsx","restricted":false,"version":1,"datasetVersionId":139651,"dataFile":{"id":3194691,"persistentId":"doi:10.7910/DVN/OWJEUN/9YSWKN","pidURL":"https://doi.org/10.7910/DVN/OWJEUN/9YSWKN","filename":"2012-2018 Orange Book Patents IPRs Database.xlsx","contentType":"application/vnd.openxmlformats-officedocument.spreadsheetml.sheet","filesize":376748,"description":"This database contains information regarding all 412 IPRs filed against 230 Orange Book (OB) patents between 03/16/2012 and 03/16/2018 including  1) their outcomes, 2) type of petitioners filing these IPRs, 3) type of drug exclusivity and OB products related to the OB patents, 3) whether the OB patents were subsequently acquired, and 4) the types of diseases the OB patents treated. \r\n\r\nI have written a paper based on my analysis of this data titled \"Maintaining the Balance: An Empirical Study on Inter Partes Review Outcomes of Orange Book-Listed Drug Patents and its Effect on Hatch-Waxman Litigation,\" which can be found here: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3188995","storageIdentifier":"s3://dvn-cloud:164b8ef1bd2-af757ff28751","rootDataFileId":-1,"md5":"0e427851218d2e1b25fde88eddec30a5","checksum":{"type":"MD5","value":"0e427851218d2e1b25fde88eddec30a5"}}}]}}}